A phase I clinical trial of KCP-400 for chronic pain.
Latest Information Update: 24 Feb 2017
Price :
$35 *
At a glance
- Drugs KCP 400 (Primary)
- Indications Pain
- Focus Adverse reactions
- 24 Feb 2017 New trial record
- 22 Feb 2017 According to Kineta media release, company is planning to initiate this trial in mid-2018.